(Q43608984)

25 November 2017

Type 2 diabetes and the risk of mortality among patients with prostate cancer (English)

1 reference

25 November 2017

1 reference

1 reference

Leah Bensimon

1

1 reference

25 November 2017

Hui Yin

2

1 reference

25 November 2017

Samy Suissa

3

1 reference

25 November 2017

Michael N Pollak

4

1 reference

25 November 2017

Laurent Azoulay

5

1 reference

25 November 2017

3 January 2014

1 reference

25 November 2017

Cancer Causes & Control

1 reference

25 November 2017

25

1 reference

25 November 2017

3

1 reference

25 November 2017

329-338

1 reference

https://scigraph.springernature.com/pub.10.1007/s10552-013-0334-6

25 November 2017

0 references

cites work

Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Prostate cancer mortality in Taiwanese men: increasing age-standardized trend in general population and increased risk in diabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

A prospective study of the associations between treated diabetes and cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Use of the UK General Practice Research Database for pharmacoepidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Validation of information recorded on general practitioner based computerised data resource in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Clinical information for research; the use of general practice databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Validation of the diagnosis of venous thromboembolism in general practice database studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Validity of the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Validation and validity of diagnoses in the General Practice Research Database: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

Competing risks bias arising from an omitted risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-013-0334-6

10.1007/S10552-013-0334-6

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

25 November 2017

0 references

1 reference